A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Trial details
- Registry ID
- NCT06292923
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsNCT06292923 | TLSA | Phase 2 | Completed | 2026-09-17Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |